Advanced Search

 

Study ID Status Title Patient Level Data
201884 Completed Clinical Evaluation of Efficacy at 2 Weeks of Duac® Fixed Dose Combination Gel in Treatment of Facial Acne Vulgaris in Japanese Subjects
201889 Completed Meta-analysis of risk of intussusception after the first and the second dose of Rotarix and Rotateq
201893 Recruiting A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2820151 in Subjects with Advanced or Recurrent Solid Tumors
201897 Completed An Open-label, Randomized, Single Dose, Two-way Crossover study to Determine the Bioavailability of one Fixed Dose Combination Capsule Formulation of Dutasteride and Tamsulosin Hydrochloride (0.5 mg/0.2 mg) Relative to Coadministration of one Dutasteride 0.5 mg capsule and one Tamsulosin Hydrochloride 0.2 mg tablet in Healthy Male Subjects in the Fed and Fasted States
201908 Active not recruiting HO-14-15413 - Evidence Synthesis and Mixed Treatment Comparison of Efficacy of Treatments for the Maintenance of Asthma (annual updates)
201909 Completed An open-label study investigating critical and overall errors following 14 days of treatment with SERETIDE Metered Dose Inhaler (EVOHALER) in adult subjects with controlled asthma currently using the SERETIDE DISKUS Inhaler Study Listed on ClinicalStudyDataRequest.com
201925 Active not recruiting HO-14-15482 - Indirect treatment comparisons of trametinib versus vemurafenib in metastatic melanoma
201926 Active not recruiting Burden of Herpes zoster and post-herpetic neuralgia among people ≥ 50 years old in France: the POSTHER study
201928 Recruiting A randomised, double-blind, placebo-controlled study to evaluate the safety, efficacy and changes in induced sputum and blood biomarkers following daily repeat doses of inhaled GSK2269557 for 12 weeks in adult subjects diagnosed with an acute exacerbation of Chronic Obstructive Pulmonary Disease
201929 Recruiting Efficacy of ropinirole controlled-release on the motor symptoms in advanced Parkinson’s disease patients: A post-hoc analysis of Japanese phase III clinical trial (Study ID: 201929)
201933 Active not recruiting Drug Use Investigation for Tivicay® tablet (HRD Cooperative Investigation)
201934 Recruiting An investigation of drug concentrations in hair and sweat of subjects with respiratory diseases following the exposure of inhaled chronic respiratory therapies as a future means of assessing treatment related compliance
201935 Recruiting Etude des conditions d'utilisation et du profil de securite de'allli OR Study of the conditions of use and safety profile of Alli
201954 Active not recruiting PRJ2379: A retrospective cohort study to assess the utilization of albiglutide among women of child bearing age in the U.S.
201955 Completed Incidence of Gall Bladder Related Events Among Type 2 Diabetes Patients
201956 Recruiting A Long-term Access Programme for Subjects with Severe Asthma who Participated in a GSK-sponsored Mepolizumab Clinical Study
201958 Completed An open label, six-period cross-over, single and repeat dose study to determine the pharmacokinetics of fluticasone furoate and GSK961081 when administered alone, in combination, or concurrently via the ELLIPTA
201959 Completed A Phase III study for the evaluation of the immunogenicity and reactogenicity of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 season Southern Hemisphere) in adults 18 years of age and above Study Listed on ClinicalStudyDataRequest.com
201964 Recruiting A Phase 1 study to demonstrate the relative bioavailability of fixed dose combinations of ambrisentan and tadalafil in healthy subjects
201973 Recruiting A phase I/II dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with fulvestrant in subjects with ER+ breast cancer
201974 Active not recruiting A study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on viral proteins encoded by chimpanzee-derived adenovector (ChAd155-RSV) (GSK3389245A) in healthy adults
201986 Completed PGx7611: Genetic Investigation of ALT elevations in Eltrombopag studies in ITP subjects
202007 Completed A Double-Blind, Placebo-Controlled, Dose-Escalation, First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects
202012 Completed PRJ2429: Effect of inhaled corticosteroid (ICS) particle size on asthma efficacy and safety outcomes: A systematic literature review and meta-analysis
202024 Not yet recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of Benlysta administered in Korean subjects with SLE

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.